Pulished : September, 2019
ID: 142
Region: Global
Share on

The Global Clinical Trial Market is predicted to reach USD 21.42 billion with a CAGR of 7.75% according to Market Data Forecast report

Pulished: September, 2019
ID: 142
Share on

The Global Clinical Trial Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Global Clinical Trial Market is estimated to be $ 14.75 billion and predicted to rise to $ 21.42 billion with a CAGR of 7.75%. The market is segmented by phase (Phase I, Phase II, Phase III), by design (Interventional trials, Observational trials, Expanded Access trials), by indications (Autoimmune, Blood disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

The market for Clinical Trial is mainly driven due to alliances between the pharma-biotech companies and the clinical research organizations, increasing demand for outsourcing clinical development and increasing demand of innovative solutions in healthcare industry. But, the market growth can be hampered due to emerging shortage of clinical resources such as lack of naïve disease population, well trained labor, and sound medical infrastructure are delaying the process to initiate trials.

By indication, Cancer and CNS are the largest market share contributors to the market. Segments like Gastrointestinal, Circulatory, Dermatology and Mental Disorders are moving with high CAGR due to their increasing occurrence of problems related to these indications in people.

Geographically, Global market for Clinical Trial is segmented into North America, Asia Pacific, Latin America, Europe, and Middle-East and Africa.  North America is the biggest market in terms of market share across the globe, followed by Europe. Ample availability of funds to outsource clinical trials serves as the major growth driver for the North America. The spread of analytics and awareness of its potential are increasing at a rapid rate in Europe. The Clinical Trial market in the Asia-Pacific region is projected to grow at the highest CAGR, which is greatly due to initiatives from the government and contributions from academic laboratories, which helped augment growth.

Chiltern, Omnicare, PPD, Parexel, Kendle, Quintles, ICON Plc, and Charles River, are the major players of Global Clinical Trial market.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-clinical-trials-market-1651/” and checkout our recent reports in the Pharmaceuticals category at “http://www.marketdataforecast.com/research-reports/healthcare/pharmaceuticals-1/” For more insights and up-to-date industry news don’t forget subscribing to our newsletters.